
- Home
- News
- DDW Exclusive Content
- COVID-19
- Opinion
- Business
- Regulatory
- Intelligence
Categories
Latest Industry Intelligence
- Cancer Research
- Webinars
- Podcasts
- Archive
- Videos
This is the latest episode of the free DDW podcast, “What does gene-based medicine have to offer?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. The articles are called “Lipidomics in biomedical research: chance and challenges” and “Exploring gene-based medicine’s true potential”. In the first article, Afrisha […]
Listen nowThis is the latest episode of the free DDW podcast, “Is customisation healthcare’s secret weapon?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. The articles are called “Optimising vaccine production through customisation” and “Exploring iPSCs for individual and population health applications”. In the first article, “Optimising vaccine […]
Listen nowThis is the latest episode of the free DDW podcast, “Scientific data management: What does your lab need?”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 and Volume 22, Issue 4 – Fall 2021 of DDW. The articles are called “The benefits of bioinformatics in genomics sequencing” and “LIMs […]
Listen nowThe latest episode of the free DDW podcast is titled “A comprehensive analysis of European biotech”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas. The articles are “Innovation and opportunity within Europe’s biotech sector”, “Europe’s emerging biotechs: Challenges, opportunities and funding”, and […]
Listen nowThe latest episode of the free DDW podcast is titled “What do we know about lab automation?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas. The articles are “What has 2020 taught us about lab automation?” and “Enhancing drug discovery with laboratory informatics […]
Listen nowThe latest DDW Sitting Down With sponsored podcast features Dominque Bröhl and Evert-Jan Uringa, Scientific Program Managers at Taconic Biosciences, who discuss how mouse model generation can be accelerated without any loss of quality. They offer insight into the latest developments, innovation and challenges in mouse model generation, how timelines can be accelerated without compromising […]
Listen nowThis is the latest episode of the free DDW podcast, “What can we learn from the genome?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW and read aloud by Megan Thomas. The articles are called “Reproducibility in single cell genomic analysis” and “The road to global pharmacogenomics”. […]
Listen nowThis is the latest episode of the free DDW podcast, “From here to there: What lies ahead for drug discovery”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW and read aloud by Megan Thomas. The articles are called “The complexity of disease biology gives opportunities for drug […]
Listen nowThe latest free-to-listen DDW podcast episode is titled “Therapeutics: Changing the way we treat disease”. It covers two articles written for Volume 22, Issue 2 – Spring 2021 of the Drug Discovery World Magazine and has been narrated by DDW’s Megan Thomas. These articles are titled: “Avoiding double strand breaks on the CRISPR path to therapeutic discovery” and “The […]
Listen nowThe latest free-to-listen DDW podcast episode is titled “Using biotechnology to maximise drug discovery output”. It covers two articles written for Volume 22, Issue 2 – Spring 2021 of the Drug Discovery World Magazine and has been narrated by DDW’s Megan Thomas. These articles are titled: “The important integration of medicinal chemistry in Hit-to-Lead discovery” and “With so many technologies for genetically […]
Listen nowThe latest sponsored DDW Sitting Down With podcast features Lisa Moneymaker and Paul O’Donohoe of Medidata and they talk to us about decentralised clinical trials. Medidata technology has helped to bring Covid-19 vaccines and treatments to market in record timelines and the company was the first to have launched a fully end-to-end Decentralised Clinical Trials (DCT) offering. Decentralised clinical trials, described as the ‘new normal’ and the future of […]
Listen now